Vita34 ApS: Financial statements 2013
CVR: 27511759
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
Vita34 ApS (CVR 27511759) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 5,043,717 and a net result of DKK 538,791 compared with DKK 929,516 the year before. That is a decrease of 4.7% compared with the year before. The profit margin was 10.7%. Equity in the 2013 report amounted to DKK 2,732,106. The solvency ratio was 8%.
- Revenue
- DKK 5,043,717
- Gross Profit
- DKK 4,474,384
- Profit/Loss
- DKK 538,791
- Equity
- DKK 2,732,106
- Total Assets
- DKK 34,231,600
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | 5M | 4.5M | 539K | 2.7M | - |
| 2012 | 5.3M | 4.6M | 930K | 2.2M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
Vita34 ApS has published its annual report for 2012. Revenue came to DKK 5,294,144, and the net result was DKK 929,516.
As of January 1, 2013, AP STATSAUTORISEREDE REVISORER P/S has been appointed auditor of Vita34 ApS.
About Vita34 ApS
Vita34 ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2004. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named StemCare ApS and BIOBANK DANMARK ApS. The management consists of Marion Bartel and Vivien Weise. The company is owned by FamiCord AG. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 3,842,095 and a net result of DKK 1,034,065 compared with DKK 1,030,138 the year before. Equity in the 2025 report amounted to DKK 5,982,880.